Peer-reviewed veterinary case report
Laser treatment for glaucoma after lens removal in dogs
By O'Reilly, A et al.·Published in Veterinary ophthalmology·2003·Animal Eye Care, Australia·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: The use of transscleral cyclophotocoagulation with a diode laser for the treatment of glaucoma occurring post intracapsular extraction of displaced lenses: a retrospective study of 15 dogs (1995-2000).
- Species:
- dog
Plain-English summary
Fifteen dogs developed glaucoma after having surgery to remove displaced lenses, and they were treated with a laser procedure called transscleral cyclophotocoagulation (TSCP). While this treatment initially helped reduce eye pressure and maintain some vision, its effects only lasted for a short time, typically 1 to 3 months. Many dogs needed additional treatments or medications to keep their eye pressure under control, and over two years, more dogs required further surgical interventions or were lost to follow-up.
People also search for: dog glaucoma treatment · laser surgery for dog eye problems · aphakic glaucoma in dogs · managing eye pressure in dogs
Abstract
The objective of this retrospective study was to evaluate transscleral cyclophotocoagulation (TSCP) using a diode laser for treating aphakic glaucoma that developed after intracapsular lens extraction (ICLE) had been performed for displaced lenses. Records of 15 dogs (21 eyes) were reviewed. The intraocular pressure (IOP) and the presence of vision were recorded at the time of ICLE and TSCP and at 1, 3, 6-9, 12 and 24 months post TSCP. The glaucoma was considered controlled if the IOP was less than 25 mmHg. The results indicated that the effectiveness of TSCP using a diode laser for treating aphakic glaucoma was of a short-term duration (1-3 months), with three patients needing repeat TSPC. In addition, adjunctive antiglaucoma medications were often required to maintain an adequately controlled IOP. Over the 24-month period the number of dogs requiring intrascleral prosthesis, intraocular gentamicin or enucleation, or that were lost to follow-up, increased.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/12753611/